3 Biotech Stocks That Jumped Last Week

3 Biotech Stocks That Jumped Last Week

Hardly a week goes by without big gains from at least a few members of this industry, which produces about one new publicly traded company per week. Read on to see why investors pushed these three biotech stocks a lot higher last week. This company's lead drug, sotagliflozin, earned approval in the EU a couple of years ago, but the FDA raised concerns that kept it from reaching U.S. pharmacy shelves.